Saraf and Partners acted for Fortis Healthcare Limited in relation to the acquisition of 31.52% equity stake in its subsidiary, Agilus Diagnostics Limited, from three private equity investors, namely – NYLIM Jacob Ballas India Fund III LLC, Resurgence PE Investments Limited and IFC – International Finance Corporation for a cash consideration of approx. INR 1770 crores (approx. USD 207 million).
The transaction team was led by Senior Partner Vaibhav Kakkar, Partner Sahil Arora and Partner Debarpan Ghosh.
Source: Saraf & Partners’ LinkedIn Page
© Copyright 2022. All Rights Reserved.